Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation, tax credit, research, amount?
- Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation, tax credit, research, amount of $203.01K in Q4 2025.
- What does effective income tax rate reconciliation, tax credit, research, amount mean?
- The total dollar amount of research and development tax credits recognized during the period to reduce income tax liability. This reflects the tax benefits derived from the company's investment in innovation and clinical development activities.